• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎与脑血管-心血管系统:目前我们了解多少?

Coronavirus Disease 2019 and the Cerebrovascular-Cardiovascular Systems: What Do We Know So Far?

机构信息

Department of Radiology Mayo Clinic Rochester MN.

Department of Neurosurgery Mayo Clinic Rochester MN.

出版信息

J Am Heart Assoc. 2020 Jul 7;9(13):e016793. doi: 10.1161/JAHA.120.016793. Epub 2020 May 12.

DOI:10.1161/JAHA.120.016793
PMID:32393136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7670533/
Abstract

The severe acute respiratory syndrome coronavirus 2 pandemic of 2019 to 2020 has resulted in multiple hospitalizations, deaths, and economic hardships worldwide. Although respiratory involvement in patients with coronavirus disease 2019 (COVID-19) is well known, the potential cardiovascular and cerebrovascular manifestations are less understood. We performed a PubMed and Google Scholar search and reviewed relevant literature on COVID-19 and cardiovascular system involvement. Severe acute respiratory syndrome coronavirus 2 possesses high affinity for angiotensin-converting enzyme 2 receptor, which is highly concentrated in the lungs and cardiovascular tissue, thereby provoking concern for cardiovascular involvement in COVID-19 cases. Preexisting cardiovascular and cerebrovascular disease has been shown in previous reports to be a risk factor for severe infection. On the basis of our review of published studies, COVID-19 patients may be more likely to experience acute cardiac injury, arrhythmia, coagulation defects, and acute stroke and are likely to have poorer outcomes as a result. As the COVID-19 pandemic continues, more data about potential cardiovascular and cerebrovascular manifestations of the disease are required.

摘要

2019 年至 2020 年期间爆发的严重急性呼吸综合征冠状病毒 2 型疫情导致全球范围内出现了大量住院、死亡和经济困难。尽管人们熟知新型冠状病毒病(COVID-19)患者的呼吸道受累情况,但对其潜在的心血管和脑血管表现了解较少。我们进行了 PubMed 和 Google Scholar 检索,并对 COVID-19 和心血管系统受累的相关文献进行了综述。严重急性呼吸综合征冠状病毒 2 对血管紧张素转换酶 2 受体具有高亲和力,而这种受体在肺部和心血管组织中高度集中,因此引发了对 COVID-19 病例中心血管受累的关注。既往报告显示,先前存在的心血管和脑血管疾病是严重感染的危险因素。根据我们对已发表研究的综述,COVID-19 患者更有可能出现急性心脏损伤、心律失常、凝血缺陷和急性中风,并且可能因此导致预后较差。随着 COVID-19 大流行的持续,需要更多关于该病潜在心血管和脑血管表现的相关数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f2/7670533/6812d195d0b5/JAH3-9-e016793-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f2/7670533/6812d195d0b5/JAH3-9-e016793-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f2/7670533/6812d195d0b5/JAH3-9-e016793-g001.jpg

相似文献

1
Coronavirus Disease 2019 and the Cerebrovascular-Cardiovascular Systems: What Do We Know So Far?新型冠状病毒肺炎与脑血管-心血管系统:目前我们了解多少?
J Am Heart Assoc. 2020 Jul 7;9(13):e016793. doi: 10.1161/JAHA.120.016793. Epub 2020 May 12.
2
COVID-19: a conundrum to decipher.COVID-19:一个待破译的谜。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
3
Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the Editors.关于 2019 年冠状病毒病和心血管疾病的当前观点:编辑的白皮书。
J Am Heart Assoc. 2020 Jun 16;9(12):e017013. doi: 10.1161/JAHA.120.017013. Epub 2020 Apr 29.
4
Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges.慢性阻塞性肺疾病与新冠疫情:相互挑战
Respir Med Res. 2020 Nov;78:100764. doi: 10.1016/j.resmer.2020.100764. Epub 2020 May 11.
5
Cardiovascular system is at higher risk of affecting by COVID-19.心血管系统受新冠病毒影响的风险更高。
Acta Biomed. 2020 Sep 7;91(3):e2020018. doi: 10.23750/abm.v91i3.9718.
6
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.新型冠状病毒肺炎与心血管疾病:从基础机制到临床展望。
Nat Rev Cardiol. 2020 Sep;17(9):543-558. doi: 10.1038/s41569-020-0413-9. Epub 2020 Jul 20.
7
Cardiac manifestations in COVID-19 patients-A systematic review.新冠病毒感染患者的心脏表现——一项系统综述
J Card Surg. 2020 Aug;35(8):1988-2008. doi: 10.1111/jocs.14808. Epub 2020 Jul 11.
8
Prevalence of Cardiovascular Comorbidities in Coronavirus Disease 2019, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome: Pooled Analysis of Published Data.2019 年冠状病毒病、严重急性呼吸综合征和中东呼吸综合征合并心血管合并症的流行情况:已发表数据的汇总分析。
J Am Heart Assoc. 2020 Sep;9(17):e016812. doi: 10.1161/JAHA.120.016812. Epub 2020 Jul 15.
9
Features of severe COVID-19: A systematic review and meta-analysis.严重 COVID-19 的特征:系统评价和荟萃分析。
Eur J Clin Invest. 2020 Oct;50(10):e13378. doi: 10.1111/eci.13378. Epub 2020 Aug 29.
10
Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease.2019 年冠状病毒病(COVID-19)大流行对儿科和成人先天性心脏病的影响。
J Am Heart Assoc. 2020 Jun 16;9(12):e017224. doi: 10.1161/JAHA.120.017224. Epub 2020 May 22.

引用本文的文献

1
Unveiling the hidden effect of multi-morbidities on the severity of Covid-19: a latent class analysis approach.揭示多种合并症对新冠病毒疾病严重程度的潜在影响:一种潜在类别分析方法。
BMC Public Health. 2025 Apr 4;25(1):1272. doi: 10.1186/s12889-025-22523-8.
2
Radiologic and Clinical Characteristics of Stroke Patients with Covid-19: A Case-Control Study.新冠肺炎中风患者的放射学和临床特征:一项病例对照研究。
Noro Psikiyatr Ars. 2024 Nov 30;61(4):345-350. doi: 10.29399/npa.28642. eCollection 2024.
3
COVID-19 Infection Raising Suspicions of a Connection between Vascular Damage and Thrombus Formation.

本文引用的文献

1
Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.新型冠状病毒肺炎后急性脑血管病:一项单中心、回顾性、观察性研究。
Stroke Vasc Neurol. 2020 Sep;5(3):279-284. doi: 10.1136/svn-2020-000431. Epub 2020 Jul 2.
2
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China.中国武汉因 2019 年冠状病毒病(COVID-19)感染而住院的高血压患者中,肾素-血管紧张素系统抑制剂与严重程度或死亡风险的关系。
JAMA Cardiol. 2020 Jul 1;5(7):825-830. doi: 10.1001/jamacardio.2020.1624.
3
新冠病毒感染引发对血管损伤与血栓形成之间关联的怀疑。
Intern Med. 2024 Sep 15;63(18):2567-2570. doi: 10.2169/internalmedicine.3897-24. Epub 2024 Jul 4.
4
Traditional Tibetan medicine to fight against COVID-19: Basic theory and therapeutic drugs.藏医药抗击新冠疫情:基础理论与治疗药物
Front Pharmacol. 2023 Feb 16;14:1098253. doi: 10.3389/fphar.2023.1098253. eCollection 2023.
5
COVID-19 free pathways decrease postoperative complications in patients undergoing elective colorectal surgery.COVID-19 阴性路径可降低择期结直肠手术患者的术后并发症发生率。
Surg Pract Sci. 2022 Dec;11:100125. doi: 10.1016/j.sipas.2022.100125. Epub 2022 Sep 1.
6
The Potential Impact of COVID-19 Virus on the Heart and the Circulatory System.新冠病毒对心脏及循环系统的潜在影响。
Infect Drug Resist. 2022 Mar 22;15:1175-1189. doi: 10.2147/IDR.S351318. eCollection 2022.
7
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective.从进化角度看血管防御、止血、癌症和血小板生物学。
Cancer Metastasis Rev. 2022 Mar;41(1):147-172. doi: 10.1007/s10555-022-10019-5. Epub 2022 Jan 12.
8
SARS-CoV-2-Associated Cerebrovascular Disease Amid the COVID-19 Pandemic: A Systematic Review.新冠疫情期间与严重急性呼吸综合征冠状病毒2相关的脑血管疾病:一项系统综述
Infect Drug Resist. 2021 Nov 26;14:4967-4975. doi: 10.2147/IDR.S340314. eCollection 2021.
9
Using Clinical and Echocardiographic Characteristics to Characterize the Risk of Ischemic Stroke in Patients with COVID-19.利用临床和超声心动图特征来描述 COVID-19 患者的缺血性卒中风险。
J Stroke Cerebrovasc Dis. 2022 Feb;31(2):106217. doi: 10.1016/j.jstrokecerebrovasdis.2021.106217. Epub 2021 Nov 8.
10
Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A Review.了解严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的分子生物学与冠状病毒病(COVID-19)大流行:综述
Infect Drug Resist. 2021 Jun 16;14:2259-2268. doi: 10.2147/IDR.S306441. eCollection 2021.
Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations.
新型冠状病毒肺炎患者深静脉血栓形成的激增:初步数据及可能原因
J Vasc Surg Venous Lymphat Disord. 2020 Jul;8(4):694-695. doi: 10.1016/j.jvsv.2020.04.004. Epub 2020 Apr 17.
4
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
5
First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.首例 COVID-19 合并暴发性心肌炎:病例报告及启示
Infection. 2020 Oct;48(5):773-777. doi: 10.1007/s15010-020-01424-5. Epub 2020 Apr 10.
6
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉住院的 2019 年冠状病毒病患者的神经系统表现。
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
7
Will Complement Inhibition Be the New Target in Treating COVID-19-Related Systemic Thrombosis?补体抑制会成为治疗新冠病毒相关全身性血栓形成的新靶点吗?
Circulation. 2020 Jun 2;141(22):1739-1741. doi: 10.1161/CIRCULATIONAHA.120.047419. Epub 2020 Apr 9.
8
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.新型冠状病毒肺炎患者的凝血障碍与抗磷脂抗体
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
9
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.鉴定 2019 新型冠状病毒的受体结合域(RBD):作为病毒附着抑制剂和疫苗开发 RBD 蛋白的意义。
Cell Mol Immunol. 2020 Jun;17(6):613-620. doi: 10.1038/s41423-020-0400-4. Epub 2020 Mar 19.
10
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic.心血管考虑因素在 COVID-19 大流行期间的患者、医护人员和卫生系统。
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371. doi: 10.1016/j.jacc.2020.03.031. Epub 2020 Mar 19.